Détails de l’appel d’offres prévu

Intitulé:
FWC for human iPSC cell derivatives
Pouvoir adjudicateur:
European Commission, Joint Research Centre - Ispra (JRC-IPR)
Date de commencement:
26/08/2020
Date limite pour manifester son intérêt:
11/09/2020
Statut:
Fermé
Informations
JRC/IPR/2020/MVP/2074-ExA
FWC for human iPSC cell derivatives
Framework contract for the procurement of human induced pluripotent stem cells (hiPSC). The cells will be used in a study to investigate the developmental neurotoxic (DNT) effects of a well-defined chemical library. The results will feed into an international collaboration coordinated by Organisation for Economic Co-Operation and Development (OECD) and European Food Safety Authority (EFSA) which aims to improve DNT testing. For this aim, we will first procure neuronal cells (glutamatergic (excitatory) human neurons and astrocytes) but this framework contract can be also exploited in future studies utilising different hiPSC types such as liver cells.
Fournitures
Procédure négociée planifiée pour les marchés de moyenne/faible valeur
Fermé
Non validé
Sans objet
Conditions de participation
Étapes
26/08/2020 00:00
11/09/2020 23:59
13/09/2020 - 25/09/2020
Lots L'appel d'offres ne contient aucun lot.
Avis Nothing found to display.